General Resources / Legal Resources / Medical
Resources / Briefing Papers / State Activity
Hospital Closures / Preventable
Tragedies / Press Room / Search
Our Site / Home
McEvoy JP, Freter S, Everett G, Geller JL, Appelbaum PS, Apperson LJ & Roth L. (1989).
Journal of Nervous and Mental Disease, 177(1): 48-51.
RELEVANCE FOR EARLY INTERVENTION
Patients with schizophrenia were followed from 2 � to 3 �
years after discharge from the hospital. Although symptoms of psychosis improved in nearly
all of the patients over the course of the initial hospitalization, improvement in insight
was seen only in those patients who had voluntarily agreed to being hospitalized. Patients
who had been involuntarily committed to the hospital did not show a similar improvement in
level of insight into the illness. Furthermore, the low levels of insight persisted
throughout the follow up period only in those patients who had been involuntarily admitted
to the hospital. Not surprisingly, these same patients were more likely to be
involuntarily committed over the course of follow up. The authors conclude that an
inability to see oneself as ill seems to be a persistent trait in some patients with
schizophrenia and one that leads to involuntary commitment.
general
resources | legal resources | medical
resources | briefing papers | state activity
hospital closures | preventable
tragedies | press room | search
| home
The contents of TAC's website are copyrighted by the Treatment Advocacy Center unless otherwise indicated. All rights reserved and content may be reproduced, downloaded, disseminated, or transferred, for single use, or by nonprofit organizations for educational purposes only, if correct attribution is made. TAC is an I.R.C. � 501(c)(3) tax-exempt corporation. Donations are appreciated and are eligible for the charitable contribution deduction under the provisions of I.R.C. � 170. Please note that TAC does not accept funding from pharmaceutical companies or entities involved in the sale, marketing, or distribution of such products. Treatment Advocacy Center (TAC), 200 N. Glebe Road, Suite 730, Arlington, VA 22203 703 294 6001/6002 (phone) | 703 294 6010 (fax) | www.treatmentadvocacycenter.org (website) [email protected] (general email) | [email protected] (press contact) [email protected] (webmaster) |